BSEAGM/EGMResults14h ago
DCB Bank Ltd
Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') - Notice of Postal Ballot
DCB Bank Ltd has announced an Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding a Notice of Postal Ballot. The Bank is seeking approval from its members through electronic voting for a resolution related to the proposed business. The Postal Ballot Notice is being sent to all members whose names appear in the Register of Members/ Register of Beneficial Owners maintained by the Depositories. The remote e-Voting period will commence on October 27, 2026, and end on November 25, 2026.
BSECompany Update▲ PositiveResults14h ago
Veefin Solutions Ltd
Investor Presentation dated 26.10.2026
Veefin Solutions Ltd has announced its Investor Presentation dated 26.10.2026, highlighting its financial results for the quarter and half year ended 30th September, 2026. The presentation shows a strong revenue growth of 116.2% YoY and 83.6% YoY, respectively, with EBITDA margins improving to 55.3% and 25.5%, respectively. The company's pipeline value has increased to ₹920 cr, with 77 active deals spanning products beyond SCF and markets outside India.
BSECompany UpdateResults14h ago
Oracle Financial Services Software Ltd
Please find enclosed the copies of the newspaper publications of financial results for the three and six month period ended September 30, 2026.
Oracle Financial Services Software Ltd has published its financial results for the three and six month period ended September 30, 2026, in newspapers Financial Express and Sakal.
BSEBoard MeetingResults14h ago
Alchemist Corporation Ltd
Alchemist Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve the unaudited (Standalone & Consolidated) Financial Results of the Company, for the second quarter ended on September 30, 2026.
Alchemist Corporation Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 29/10/2026 to consider and approve the unaudited financial results for the second quarter ended on September 30, 2026.
BSECompany Update▲ PositiveResults14h ago
Bank of Maharashtra
Press release on the financial results of the Bank for the quarter and half year ended 30.09.2026
Bank of Maharashtra has announced its financial results for the quarter and half year ended 30th September 2026, showing a 25.16% growth in total global business, 21.50% increase in total global deposits, and a 29.61% growth in gross global advances. Net profit increased by 41.42% to ₹ 2,310 crore in Q2 FY27, and 34.22% to ₹ 4,330 crore for the half year ended 30.09.2026.
BSECompany UpdateResults14h ago
Kansai Nerolac Paints Ltd
Kansai Neorlac Paints Limited, Q2 FY- 2026- 27 Financial Results Conference Call - Invite
Kansai Nerolac Paints Ltd. invites analysts and investors to a conference call on November 5, 2026, to discuss Q2 FY 2026-27 financial results. The call will be represented by the company's MD, CFO, and Director of Corporate Planning, IT & Materials.
BSECompany UpdateResults14h ago
KEC International Ltd
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Company will hold an Earnings Conference Call on its Unaudited Financial Results for the quarter and half year ended September 30, 2026, on Tuesday, November 03, 2026, at 10:00 a.m. (IST)
KEC International Ltd has announced an earnings conference call for its unaudited financial results for the quarter and half year ended September 30, 2026, to be held on November 03, 2026.
BSECompany UpdateResults14h ago
Indobell Insulations Ltd
Statement for Deviation or Variation for proceeds of Public Issue
Indobell Insulations Ltd has announced its unaudited financial results for the half year ended September 30, 2026, along with the Limited Review Report and Utilisation Certificate for IPO proceeds. The Board of Directors has approved the increase in salary for Directors, KMPs, and Senior Management Personnel. The company has also disclosed its balance sheet as at September 30, 2026.
BSECompany Update14h ago
Kilitch Drugs India Ltd
We are hereby submitting the copy of the newspaper publication for information
Kilitch Drugs India Ltd has submitted a newspaper publication for information regarding the Notice of EGM and E-voting, as per Regulation 30 and 47 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015.
BSECompany Update▲ PositiveResults14h ago
Mankind Pharma Ltd
Investor Presentation on Financial Results of the Company for Q2 & H1FY27
Mankind Pharma Ltd has announced its investor presentation on financial results for Q2 & H1 FY27, showcasing a 17.3% YoY growth in revenue, with EBITDA margins improving by 210 bps to 27.1%. The company's domestic business grew 15.9% YoY, driven by strong double-digit growth in both Mankind and BSV specialty business. Key brands like Pantakind, Dydroboon, and Cefakind-CV showed significant growth in Q2FY27.
BSEBoard MeetingResults14h ago
KEC International Ltd
KEC International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve the Consolidated and Standalone Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026
KEC International Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 02/11/2026 to consider and approve the Consolidated and Standalone Unaudited Financial Results for the quarter and half year ended September 30, 2026.
BSECompany Update▲ PositiveResults14h ago
Bank of Maharashtra
Investor Presentation on the financial results for the quarter and half year ended 30.09.2026
Bank of Maharashtra has released its investor presentation for the quarter and half-year ended 30.09.2026, highlighting a 41.42% increase in net profit, 30.86% increase in operating profit, and 21.76% increase in net interest income. The bank's total business has grown by 25.16% YoY, with a CASA deposit growth of 21.50% and a gross advances growth of 29.61%. The bank's return on assets has improved to 2.02%, and the gross NPA ratio has decreased to 1.25%. The bank's capital adequacy ratio stands at 12.12%.
BSECompany Update▲ PositiveResults14h ago
Mankind Pharma Ltd
Press release on financial results Q2&H1FY27
Mankind Pharma Ltd reported a 17% YoY growth in revenue, 27% YoY growth in EBITDA, and 38% YoY growth in PAT for Q2 FY27. Domestic business grew 16% YoY, driven by strong double-digit growth in Mankind and BSV specialty business. The company also announced a 33% YoY growth in international revenue.
BSECompany Update▲ PositiveResults14h ago
Ather Energy Ltd
Pursuant to the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith a copy of the Investor Presentation on the Company''s performance for the quarter and half year ended September 30, 2026.
Ather Energy Ltd has released an investor presentation for the quarter and half year ended September 30, 2026, highlighting a 82% growth in industry registrations, highest ever E2W penetration, and new product launches including Ather TrueHealth, Ather Node, and Ather Bedrock.
BSEBoard MeetingResults14h ago
Minda Corporation Ltd
Minda Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Consider and approve Quarterly and half yearly financial results ended 30th September 2026
Minda Corporation Ltd has scheduled a board meeting on November 3, 2026, to consider and approve the company's quarterly and half-yearly financial results for the period ended September 30, 2026. The trading window for dealing in the company's equity shares will be closed from October 1, 2026, until 48 hours after the results are made public.
BSECompany UpdateRegulatory14h ago
Integra Engineering India Ltd
Submission of copies of newspaper advertisement regarding proposed transfer of shares under SEBI Circulars
Integra Engineering India Ltd submitted copies of newspaper advertisements regarding proposed transfer of shares under SEBI Circulars. The advertisements were published on October 26, 2026, in Business Standard and Loksatta-Jansatta. The company's website also has a copy of the published advertisement.
BSECompany UpdateResults14h ago
Mankind Pharma Ltd
Scheme of arrangement for amalgamation of Prolijune Lifescinces Private Limited (WOS) with Mankind Pharma Limited
Mankind Pharma Ltd has approved the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The company has also considered and approved the Scheme of Arrangement for amalgamation of its wholly owned subsidiaries with the company, subject to necessary statutory and regulatory approvals.
BSECompany UpdateResults15h ago
Crizac Ltd
Crizac Limited has informed the Exchange about the Schedule of the meet of the investors and analysts to be held on Monday 2nd November, 2026 at 12.00 PM IST
Crizac Ltd has informed the exchange about the schedule of an investor and analyst meet to be held on November 2, 2026, to discuss the company's results for the quarter and half year ended September 30, 2026.
BSEBoard MeetingResults15h ago
Praruh Technologies Ltd
Praruh Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve Intimation of Board meeting to 1. Consider and approve the Un-Audited Financial Results for the half year ended on 30th September, 2026;
2. To consider the declaration of interim dividend for the financial year 2026-27
Praruh Technologies Ltd has scheduled a board meeting on October 29, 2026, to consider and approve the un-audited financial results for the half year ended on September 30, 2026, and to consider the declaration of an interim dividend for the financial year 2026-27.
BSECompany UpdateResults15h ago
Mankind Pharma Ltd
Scheme of arrangement for amalgamation of Pavi Buildwell Private Limited (WOS) with Mankind Pharma Limited
Mankind Pharma Ltd approved the unaudited Standalone and Consolidated Financial Results for the quarter and half year ended on September 30, 2026. The company also considered and approved the Scheme of Arrangement for amalgamation of its wholly owned subsidiaries with the company.